B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal ArticleDOI
The Association of Knowledge and Behaviours Related to Salt with 24-h Urinary Salt Excretion in a Population from North and South India
Claire Johnson,Claire Johnson,Sailesh Mohan,Kris Rogers,Roopa Shivashankar,Sudhir Raj Thout,Priti Gupta,Feng J. He,Graham A. MacGregor,Jacqui Webster,Jacqui Webster,Anand Krishnan,Pallab K. Maulik,K. Srinath Reddy,Dorairaj Prabhakaran,Bruce Neal +15 more
TL;DR: Several consumer behaviours related to use of salt during food preparation and consumption of salty products were related to actual salt consumption and therefore appear to offer an opportunity for intervention and a reasonable focus for a government-led education campaign targeting salt.
Journal ArticleDOI
The impact of voluntary front-of-pack nutrition labelling on packaged food reformulation: A difference-in-differences analysis of the Australasian Health Star Rating scheme.
Laxman Bablani,Cliona Ni Mhurchu,Cliona Ni Mhurchu,Cliona Ni Mhurchu,Bruce Neal,Bruce Neal,Christopher L. Skeels,Kevin E. Staub,Tony Blakely +8 more
TL;DR: It is observed that reformulation changes following voluntary HSR labelling are small, but greater for initially unhealthy products, suggesting that mandatory labelling has the greatest potential for improving the healthiness of packaged foods.
Journal ArticleDOI
Blood pressure lowering in patients with cerebrovascular disease: results of the progress (perindopril protection against recurrent stroke study) pilot phase
TL;DR: A large number of patients with cerebrovascular disease have a high blood pressure and the risk of stroke, and previous trials of blood pressure lowering in this patient group have been inconclusive, so this research aims to establish a new standard of care for this patients.
Journal ArticleDOI
The lowering of blood pressure after stroke
Journal ArticleDOI
Efficacy and safety of Canagliflozin (CANA), an inhibitor of Sodium Glucose Co-Transporter 2 (SGLT2), added on to insulin therapy with or without oral agents in type 2 diabetes (T2D)
David R. Matthews,Greg Fulcher,Vlado Perkovic,Dick de Zeeuw,Kenneth W. Mahaffey,Julio Rosenstock,Melanie J. Davies,George Capuano,Mehul Desai,Wayne Shaw,Frank Vercruysse,Gary Meininger,Bruce Neal +12 more